Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1826
| Despition | CRYGN Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1177 | Recombinant Human Prostate Specific Antigen Protein (6×His Tag) (AC1177) | 50 µg | inquiry |
| ACPP-1195 | CaMKII gamma Blocking Peptide (AC1195) | 250 µg | inquiry |
| ACPP-1396 | Human PON2 Protein (AC1396) | 2 µg | inquiry |
| ACPP-1467 | Human SCN3B Protein (AC1467) | 2 µg | inquiry |
| ACPP-1273 | BTB/POZ domain-containing protein 7 Blocking Peptide (AC1273) | 250 µg | inquiry |
| ACPP-1757 | Human Artemin Protein (AC1757) | 5 µg | inquiry |
| ACPP-1733 | Human CRYGC Protein (AC1733) | 5 µg | inquiry |
| ACPP-1257 | MC4 Receptor Blocking Peptide (AC1257) | 250 µg | inquiry |
| ACPP-1181 | Synthetic Nanodisc Human CX3CR1 Protein (AC1181) | 10 µg | inquiry |
| ACPP-1097 | Synthetic Nanodisc Human ENTPD2 Protein (AC1097) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.